<SEC-DOCUMENT>0001176256-20-000190.txt : 20200520
<SEC-HEADER>0001176256-20-000190.hdr.sgml : 20200520
<ACCEPTANCE-DATETIME>20200519183709
ACCESSION NUMBER:		0001176256-20-000190
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200515
FILED AS OF DATE:		20200520
DATE AS OF CHANGE:		20200519

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Theratechnologies Inc.
		CENTRAL INDEX KEY:			0001512717
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A8
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35203
		FILM NUMBER:		20895160

	BUSINESS ADDRESS:	
		STREET 1:		2015 PEEL STREET
		STREET 2:		5TH FLOOR
		CITY:			MONTREAL
		STATE:			A8
		ZIP:			H3A 1T8
		BUSINESS PHONE:		514-336-7800

	MAIL ADDRESS:	
		STREET 1:		2015 PEEL STREET
		STREET 2:		5TH FLOOR
		CITY:			MONTREAL
		STATE:			A8
		ZIP:			H3A 1T8
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>theratech6knomrd200515.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER FOR MAY 15, 2020
<TEXT>
<HTML>
<HEAD>
   <TITLE>Filed by e3 Filing, Computershare 1-800-973-3274 - THERATECHNOLOGIES INC. - Form 6-K</TITLE>
</HEAD>

<BODY bgcolor="#ffffff" style="font-family: 'Times New Roman';font-size: 10pt;">
<HR noshade align="center" width="100%" size=3 margin=0>
<!--$$/page=--><A name="page_1"></A><BR><BR>

<a name="_bclPageBorder1"></a><DIV style="PADDING-LEFT: 0%; PADDING-RIGHT: 0%">

<P style="TEXT-ALIGN: center"><B><FONT size=4>UNITED STATES<BR></FONT></B><FONT size=4></FONT><FONT size=4><B><FONT size=4></FONT>SECURITIES AND EXCHANGE COMMISSION</FONT><BR></B><B>Washington, D.C. 20549</B></P>

<P style="TEXT-ALIGN: center"><B><FONT size=5>FORM 6-K</FONT></B></P>

<P style="TEXT-ALIGN: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 <BR>UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P style="TEXT-ALIGN: center"><B>May 15, 2020</B></P>

<P style="TEXT-ALIGN: center">Commission File Number: <B>001-35203</B></P>

<P style="TEXT-ALIGN: center"><B><U><FONT size=6>THERATECHNOLOGIES INC.</FONT></U><BR></B>(Translation of registrant's name into English</I>)</P>

<P style="TEXT-ALIGN: center"><B><U>2015 Peel Street, Suite 1100<BR>Montr&#233;al, Qu&#233;bec, Canada<BR>H3A 1T8<BR></u></b>(Address of principal executive office)</P>

<P style="TEXT-ALIGN: center">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</P>

<P style="TEXT-ALIGN: center">Form 20-F&nbsp;[&nbsp;&nbsp; ]&nbsp;Form 40-F [ X ]&nbsp;</P>

<P style="TEXT-ALIGN: center">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes [&nbsp;&nbsp; ] No [&nbsp;X&nbsp;]</P>

<P style="TEXT-ALIGN: center">Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</p>

<P style="TEXT-ALIGN: center">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes [&nbsp;&nbsp; ] No [&nbsp;X&nbsp;]</P>

<P style="TEXT-ALIGN: center">Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.</p>

<P style="TEXT-ALIGN: center">Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</p>

<P style="TEXT-ALIGN: center">Yes [&nbsp;&nbsp; ] No [&nbsp;X&nbsp;]</p>

<P style="TEXT-ALIGN: center">If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-______________.</p></DIV><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center SIZE=1 width="100%" noShade>

<BR>

<!--$$/page=--><A name="page_2"></A><BR>

<a name="_bclPageBorder3"></a><DIV style="PADDING-LEFT: 0%; PADDING-RIGHT: 0%">

<P style="TEXT-ALIGN: center"><B>EXHIBIT INDEX</B></P>

<DIV align=left>

<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellSpacing=0 border=0>



<TR>

   <TD style="WIDTH: 8%"></TD>

   <TD style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none" width="2%"></TD>

   <TD style="WIDTH: 90%"></TD></TR>

<TR vAlign=bottom>

   <TD style="WIDTH: 8%; BORDER-BOTTOM: #000000 1px solid" noWrap align=center><B>Exhibit</B><BR><B>Number</B></TD>

   <TD style="WIDTH: 2%" noWrap align=left><B></B></TD>

   <TD style="BORDER-BOTTOM: #000000 1px solid" width="90%" noWrap align=left><B>Exhibit Description</B></TD></TR>

<TR vAlign=bottom>

   <TD style="BACKGROUND-COLOR: #e6efff" width="8%" noWrap align=center valign="top"><a href="exhibit99-1.htm">99.1</a></TD>

   <TD style="BACKGROUND-COLOR: #e6efff" width="2%" noWrap align=left></TD>

   <TD style="BACKGROUND-COLOR: #e6efff" width="90%" align=left><a href="exhibit99-1.htm">Notice of Meeting and Record Date</a>


   </TD></TR></TABLE></DIV>

<P style="MARGIN: 0px">&nbsp;</P></DIV><BR>

<HR style="PAGE-BREAK-AFTER: always" align=center SIZE=1 width="100%" noShade>

<BR>

<!--$$/page=--><A name="page_3"></A><BR>

<a name="_bclPageBorder2"></a><DIV style="PADDING-LEFT: 0%; PADDING-RIGHT: 0%">

<P style="TEXT-ALIGN: center"><B>SIGNATURES</B></P>

<P style="TEXT-ALIGN: justify">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<DIV align=left>

<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellSpacing=0 border=0>



<TR>

   <TD width="50%"></TD>

   <TD width="4%"></TD>

   <TD width="46%"></TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left>&nbsp;</TD>

   <TD width="50%" colSpan=2 noWrap align=left><B>THERATECHNOLOGIES INC.</B></TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left></TD>

   <TD width="4%" noWrap align=left>&nbsp;</TD>

   <TD width="46%" noWrap align=left><U></U></TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left>Date: May 15, 2020</TD>

   <TD width="4%" noWrap align=left>By:</TD>

   <TD width="46%" noWrap align=left><U>/s/ Jocelyn Lafond</U></TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left>&nbsp;</TD>

   <TD width="4%" noWrap align=right></TD>

   <TD width="46%" noWrap align=left>Name: Jocelyn Lafond</TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left>&nbsp;</TD>

   <TD width="4%" noWrap align=right></TD>

   <TD width="46%" noWrap align=left>Title: Vice-President, Legal Affairs</TD></TR></TABLE></DIV>

<P style="MARGIN: 0px">&nbsp;</P></DIV><BR>

<HR align=center SIZE=3 width="100%" noShade>



</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>NOTICE OF MEETING AND RECORD DATE
<TEXT>

<HTML>
<HEAD>
   <TITLE>Exhibit 99.1</TITLE>
</HEAD>

<BODY bgcolor="#ffffff" style="font-family: 'Times New Roman';font-size: 10pt;">
<HR noshade align="center" width="100%" size=3 margin=0>
<div align="right"><strong>Exhibit 99.1</strong></div>
<!--$$/page=--><A name="page_1"></A><BR>

<a name="_bclPageBorder1"></a><DIV style="PADDING-LEFT: 0%; PADDING-RIGHT: 0%">

<DIV align=left>

<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellSpacing=0 border=0>


<TR>

   <TD width="80%"></TD>

   <TD width="20%"></TD></TR>

<TR vAlign=bottom>

   <TD width="80%" noWrap align=left></TD>

   <TD width="20%" noWrap align=left>
   <IMG border=0 src="exhibit99-1x1x1.jpg"></TD></TR>

<TR vAlign=bottom>

   <TD width="80%" noWrap align=left>&nbsp;</TD>

   <TD width="20%" noWrap align=left>1500 Robert-Bourassa Blvd., 7th Floor</TD></TR>

<TR vAlign=bottom>

   <TD width="80%" noWrap align=left>May 15, 2020</TD>

   <TD width="20%" noWrap align=left>Montreal QC, H3A 3S8</TD></TR>

<TR vAlign=bottom>

   <TD width="80%" noWrap align=left>&nbsp;</TD>

   <TD width="20%" noWrap align=left><FONT color=#0000ff><U>www.computershare.com</U></FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="80%" noWrap align=left>&nbsp;</TD>

   <TD width="20%" noWrap align=left></TD></TR>

   <TR vAlign=bottom>

   <TD width="80%" noWrap align=left>To: All Canadian Securities Regulatory Authorities</TD>

   <TD width="20%" noWrap align=left>&nbsp;</TD></TR>

   <TR vAlign=bottom>

   <TD width="80%" noWrap align=left>&nbsp;</TD>

   <TD width="20%" noWrap align=left></TD></TR>

    <TR vAlign=bottom>

   <TD width="80%" noWrap align=left><B>Subject: THERATECHNOLOGIES INC.</B></TD>

   <TD width="20%" noWrap align=left><b>&nbsp;</B></TD></TR>

   </TABLE></DIV>

<P style="TEXT-ALIGN: justify">Dear Sir/Madam:</P>

<P style="TEXT-ALIGN: justify">We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:</P>

<DIV align=left>

<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellSpacing=0 border=0>



<TR>

   <TD width="50%"></TD>

   <TD width="50%"></TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="50%" noWrap align=left>Meeting Type :</TD>

   <TD vAlign=top width="50%" noWrap align=left>Annual Meeting</TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="50%" align=left>Record Date for Notice of Meeting :</TD>

   <TD vAlign=top width="50%" noWrap align=left>June 12, 2020</TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="50%" align=left>Record Date for Voting (if applicable) :</TD>

   <TD vAlign=top width="50%" noWrap align=left>June 12, 2020</TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="50%" align=left>Beneficial Ownership Determination Date :</TD>

   <TD vAlign=top width="50%" noWrap align=left>June 12, 2020</TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="50%" align=left>Meeting Date :</TD>

   <TD vAlign=top width="50%" noWrap align=left>July 16, 2020</TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="50%" align=left>Meeting Location (if available) :</TD>

   <TD vAlign=top width="50%" noWrap align=left>Montr&#233;al, QC</TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="50%" align=left>Issuer sending proxy related materials directly to NOBO:</TD>

   <TD vAlign=top width="50%" noWrap align=left>No</TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="50%" align=left>Issuer paying for delivery to OBO:</TD>

   <TD vAlign=top width="50%" noWrap align=left>Yes</TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="50%" noWrap align=left><B>&nbsp;</B></TD>

   <TD vAlign=top width="50%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="50%" noWrap align=left><B>Notice and Access (NAA) Requirements:</B></TD>

   <TD vAlign=top width="50%" noWrap align=left>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="50%" noWrap align=left>

   <P style="MARGIN-LEFT: 4%">NAA for Beneficial Holders</P></TD>

   <TD vAlign=top width="50%" noWrap align=left>No</TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="50%" noWrap align=left>

   <P style="MARGIN-LEFT: 4%">NAA for Registered Holders</P></TD>

   <TD vAlign=top width="50%" noWrap align=left>No</TD></TR></TABLE></DIV>

<P style="TEXT-ALIGN: justify"><B>Voting Security Details:</B></P>

<DIV align=left>

<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellSpacing=0 border=0>



<TR>

   <TD width="33%"></TD>

   <TD width="33%"></TD>

   <TD width="33%"></TD></TR>

<TR vAlign=bottom>

   <TD width="33%" noWrap align=left><B>Description</B></TD>

   <TD width="33%" noWrap align=left><B>CUSIP Number</B></TD>

   <TD width="33%" noWrap align=left><B>ISIN</B></TD></TR>

<TR vAlign=bottom>

   <TD width="33%" noWrap align=left>COMMON SHARES</TD>

   <TD width="33%" noWrap align=left>88338H100</TD>

   <TD width="33%" noWrap align=left>CA88338H1001</TD></TR></TABLE></DIV>

<P style="MARGIN: 0px">&nbsp;</P>

<P style="TEXT-ALIGN: justify">Sincerely,</P>

<P style="TEXT-ALIGN: justify"><B><FONT color=#660066>Computershare<BR></FONT></B>Agent for THERATECHNOLOGIES INC.</P></DIV><BR>

<HR noshade align="center" width="100%" size=3>
</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>exhibit99-1x1x1.jpg
<TEXT>
begin 644 exhibit99-1x1x1.jpg
M_]C_X  02D9)1@ ! 0'_____  #_[@ .061O8F4 9      !_]L 0P ! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@
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M=2!>/\9^&*N&XEHT*O$&(>9YOG..H?7<NIS>,PN>0ROV6&KR_P!8'0PKX?\
MJE7#8%U,)C[X:A@98)Y=+V](_G)_8(_X);_!SX[_ /!&[XD?&'3/'GA_X5_M
M)_'[4=;\!Z3\7/B5XXU?PM\/]$\,^%?C?X6BTKX27]O%J:Z##H_Q$\0>!+&&
MYU=]%U'Q%)KFO65G:1WUE;#2-0\CM?%7@'X5_L9_\%+?V(OB1^R%\//V?_VU
MO@I^S3\)(?''Q,^%6KSZ]X=^+WPP\+_%SX%V]EJ_B.0>(?$.FV'C#6'\>^"?
M%^HZYH]]-;>.WUZ6\U*S\,W^@6^BR?ULC_@F-^QH_P"R1;?L.W?PRU2__9QL
M==N_%%CX/N/B!X_BU.T\176OWWBA=6C\66/B2S\3RRVNO:A<7]O:76J7&F,2
MEK=6-S9+]F/C/PH_X(G?\$\O@]\,?C'\*_#'PDUJ^T;X\>'M-\(_$G7=?\>^
M*[_QEJ7A/2/$6E>+;#PUI/B.VU&QN?#.D+XET/2-9O[?P]'IKZW=Z9IO]O2Z
MI#IFG16F$./<NK5LSK9AB,XQ%*KQ%2S7+<*J,82PV'H8[ U**GB89G&$Z4,%
MA9TIY;6PM>A[94*M"O2G[6H^.EXR9'B<7GV*SK&\3X[#XCCC#\19'ET,+3HS
MP."PN;937PL:N.I9]3IUL/2RO+ZN'K9%BLNQ>#>*^J8C"8S#U57KR_F2M/V7
M?@]^S9XH_P"#;7XM?"70+OPY\2?VE?BKX$\3?&CQ9'KFNW%WXRO+OXJ_LU7M
MK!/9W>I7&F:9:6&F?$OQ-X<%OHMGIT%_HDT4&I17<B&5OG;P[\*_@/\ '#]C
MK_@KY^U#^T1>6U[^UWX)^.WANY\#:_K'C'4]-\2:/JGC/XERIK-CI_@]=;M+
M+5T\77,VO^'KM-5TK66T_3=,E71AISZ5/*W]MFO_ /!-W]DOQ-!^QS;:QX$U
MJXA_8,OM*U']FA4\<>+X#X.N]%U+P'JVGOJS0ZNC>+UBOOAKX1E9/$YU-)5L
M)XY T=]>+-\Z?$K_ ((8?\$V/BW\9?'/QO\ &_P2U2]\3_$:[\0ZQXKT73?B
M#XV\/^#[WQ1XH2Z_MKQ;:Z'H6LZ>^F:[=7E[<:N#IU[;:5%K,AU2/2UN\R'I
MPGB)EMH2QE;.X8F-7VT\;0IT:N)J4J'$N*S:EEW-/&TG]5Q.7UJ6"K1E-4J*
MI^R5&M0C%2[LN\;L@Y:4LSQ7%=/'PQ#Q-7-L)0PV(Q];#83CS,.),-DGM*N:
MX>;R_'Y+B</E>)A*LJ&&5'ZNL-B<+",9_P Q6G?L_P#@?]J7X[?\$&?@-\2Q
MJ$OP_P#'W['VGP^+[+3+RZTZ\U?0?#_C_P".?BS4- 74;&XM+_3X?$,.@MH=
MY?Z?=6^H65GJ$]S8SQ7<4+KQ_P 0?V9]2^)G[:'_  5 ^$/AKX0?!3Q#X4_9
MW^'.L?#OX?7WQ]^-'BGX;Z7^RY\$/A[%;>$_A]\1/ NH:IJ-XNLKX*T33O"U
MU.WB?4+FROX]2ENM2&H/XJU*:7^Q[P9_P3(_9 \ ^//V:_B5X;\">(+?Q?\
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DKF&80I>SA2]G#&8NMB8T_94G*G3Y(U%'V=.4H0MRP;BDS__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
